Evidence map›Paper›PMID 35200587›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Anti-Metastatic Function of Extracellular Vesicles Derived from

Tomohiro Hatakenaka, Nahoko Matsuki, Seiya Minagawa, Celine Swee May Khoo, Mikako Saito

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Cancers · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tomohiro HatakenakaDepartment of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16, Naka-cho, Koganei, Tokyo 184-8588, Japan.ORCID 0000-0001-5852-7604
Nahoko MatsukiDepartment of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16, Naka-cho, Koganei, Tokyo 184-8588, Japan.
Seiya MinagawaDepartment of Industrial Technology and Innovation, Tokyo University of Agriculture and Technology, 2-24-16, Naka-cho, Koganei, Tokyo 184-8588, Japan.
Celine Swee May KhooDepartment of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16, Naka-cho, Koganei, Tokyo 184-8588, Japan.
Mikako SaitoDepartment of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16, Naka-cho, Koganei, Tokyo 184-8588, Japan.
Tokyo University of Agriculture and Technology · JP

Funding

Faculty fund of TUAT. 000
6 · The paper itself

Abstract

A metastatic melanoma cell line B16-F10 (F10) was modified to a more undifferentiated state by

Indexed as

Extracellular VesiclesMelanomaAnimalsCell Line, TumorMiceNanog Homeobox ProteinNeoplasm MetastasisTransforming Growth Factor beta1Nanog Homeobox ProteinNanog protein, mouseTGFB1 protein, humanTransforming Growth Factor beta1autovaccineextracellular vesiclesmelanomaNanog overexpressionTGF-β1

Identifiers

PMID35200587
PMCPMC8870779
OpenAlexW4213140353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.